U.S. Markets open in 4 hrs, 15 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,058.64 | 150.25 | 1.52% |
| NASDAQ | 2,150.87 | 24.82 | 1.17% |
| S&P 500 | 1,070.52 | 13.78 | 1.30% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 10.24 09:44 AM EST | |
|---|---|---|
| Day High | 10.66 03:49 PM EST |
|
| Range | 0.42 |
| Volume | 269,352 | |
|---|---|---|
| 30-Day Avg Vol | 409,000 |
|
| Difference | -34.14% |
| Market Cap | 288.34 M | |
|---|---|---|
| Mkt Cap Chg | 10.88 M |
| Shares Out | 27.20 M | |
|---|---|---|
| % Shrs Traded | 0.99% | |
| 1yr EPS Est | -0.42 |
| 52-Wk Low | 0.60 | |
|---|---|---|
| 52-Wk High | 16.65 |
|
| Range | 16.05 |
| Prev Close | 10.20 2/8/10 | |
|---|---|---|
| Today's Open | 10.32 | |
| Change | 1.18% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 3.66 M |
| Revenue (LFY) | 0 | |
|---|---|---|
| Earnings (LFY) | -51.06 M | |
| Earnings (MRQ) | -7.73 M | |
| Next Earn Est | -0.163 | |
| Next Earnings | 02/16/2010 |
|
| EPS (TTM) | -1.27 | |
| 1yr EPS Growth | 66.67% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -25.00 | |
| PEG Ratio | — | |
| Return on Equity | -78.88 | |
| Beta | 7.57 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Vanda wants to gain an advantage in the field of neurological medicine. Vanda Pharmaceuticals is a pharmaceutical company that is developing several drugs for disorders of the central nervous system. The ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.163 2/16/10 | — — |
—
—
|
| Last Quarter | -0.305 9/30/09 | -0.28 9/30/09 |
0.025
Beat
|
| 2 Quarters Ago | -0.41 6/30/09 | -0.46 6/30/09 |
-0.05
Missed
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 0.00 | 0.00 |
| Gross Profit | -148,671.00 | -530,805.00 |
| Operating Income | -7.74 M | -52.85 M |
| Net Income | -7.73 M | -51.06 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts